HUP9600764A3 - Use of a cgrp calcitonin gene related peptide antagonists for treating lichens and pruritus, and compositions containing this compound - Google Patents

Use of a cgrp calcitonin gene related peptide antagonists for treating lichens and pruritus, and compositions containing this compound

Info

Publication number: HUP9600764A3
Authority: HU; Hungary
Prior art keywords: lichens; pruritus; treating; compound; compositions containing
Prior art date: 1995-03-28

Application number

HU9600764A

Other languages

English (en)

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-28

Filing date

1996-03-27

Publication date

1998-03-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9477497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9600764(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-03-27 Application filed by Oreal filed Critical Oreal

1996-05-28 Publication of HU9600764D0 publication Critical patent/HU9600764D0/hu

1997-06-30 Publication of HUP9600764A2 publication Critical patent/HUP9600764A2/hu

1998-03-02 Publication of HUP9600764A3 publication Critical patent/HUP9600764A3/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)

HU9600764A 1995-03-28 1996-03-27 Use of a cgrp calcitonin gene related peptide antagonists for treating lichens and pruritus, and compositions containing this compound HUP9600764A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9503627A FR2732220B1 (fr)	1995-03-28	1995-03-28	Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue

Publications (3)

Publication Number	Publication Date
HU9600764D0 HU9600764D0 (en)	1996-05-28
HUP9600764A2 HUP9600764A2 (en)	1997-06-30
HUP9600764A3 true HUP9600764A3 (en)	1998-03-02

Family

ID=9477497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9600764A HUP9600764A3 (en)	1995-03-28	1996-03-27	Use of a cgrp calcitonin gene related peptide antagonists for treating lichens and pruritus, and compositions containing this compound

Country Status (14)

Country	Link
US (1)	US5935586A (hu)
EP (1)	EP0734728B2 (hu)
JP (1)	JP3043610B2 (hu)
AR (1)	AR001435A1 (hu)
AT (1)	ATE201828T1 (hu)
BR (1)	BR9601467A (hu)
CA (1)	CA2172778C (hu)
DE (1)	DE69613168T3 (hu)
ES (1)	ES2159697T5 (hu)
FR (1)	FR2732220B1 (hu)
HU (1)	HUP9600764A3 (hu)
MX (1)	MX9601151A (hu)
PL (1)	PL313511A1 (hu)
RU (1)	RU2152785C1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6958148B1 (en)	1998-01-20	2005-10-25	Pericor Science, Inc.	Linkage of agents to body tissue using microparticles and transglutaminase
JP2001233764A (ja) *	2000-02-22	2001-08-28	Hisamitsu Pharmaceut Co Inc	Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
US11517612B2 (en)	2016-11-18	2022-12-06	Nepsone Ehf	Methods of treating inflammatory skin disorders
NZ538615A (en)	2002-08-12	2008-03-28	Actavis Group Hf	Use of CGRP antagonist compounds for treatment of psoriasis
US8168592B2 (en) *	2005-10-21	2012-05-01	Amgen Inc.	CGRP peptide antagonists and conjugates
EP1957106B2 (en)	2005-11-14	2019-07-24	Teva Pharmaceuticals International GmbH	Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
JP5537441B2 (ja)	2008-03-04	2014-07-02	ファイザー・リミテッド	慢性疼痛を治療する方法
KR101519192B1 (ko)	2009-08-28	2015-05-11	리나트 뉴로사이언스 코프.	칼시토닌 유전자-관련된 펩티드에 대해 지시된 길항제 항체의 투여에 의한 내장 통증의 치료 방법
US10556945B2 (en)	2014-03-21	2020-02-11	Teva Pharmaceuticals International Gmbh	Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
SI3119431T1 (sl)	2014-03-21	2024-06-28	Teva Pharmaceuticals International Gmbh	Antagonistična protitelesa, usmerjena proti peptidu, povezanemu z genom za kalcitonin, in postopki za uporabo le-teh
AR103173A1 (es)	2014-12-22	2017-04-19	Novarits Ag	Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
PE20191148A1 (es)	2016-09-23	2019-09-02	Teva Pharmaceuticals Int Gmbh	Tratamiento de la migrana refractaria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9201425D0 (sv) *	1992-05-06	1992-05-06	Kabi Pharmacia Ab	Method and means for preventing constriction of the pupil in the eye
JP2656700B2 (ja) *	1992-10-28	1997-09-24	ファイザー製薬株式会社	置換キヌクリジン誘導体
US5445823A (en) *	1994-10-20	1995-08-29	The Procter & Gamble Company	Dermatological compositions and method of treatment of skin lesions therewith

1995
- 1995-03-28 FR FR9503627A patent/FR2732220B1/fr not_active Expired - Lifetime
1996
- 1996-03-04 DE DE69613168T patent/DE69613168T3/de not_active Expired - Lifetime
- 1996-03-04 AT AT96400456T patent/ATE201828T1/de not_active IP Right Cessation
- 1996-03-04 ES ES96400456T patent/ES2159697T5/es not_active Expired - Lifetime
- 1996-03-04 EP EP96400456A patent/EP0734728B2/fr not_active Expired - Lifetime
- 1996-03-26 BR BR9601467A patent/BR9601467A/pt active Search and Examination
- 1996-03-27 MX MX9601151A patent/MX9601151A/es unknown
- 1996-03-27 PL PL96313511A patent/PL313511A1/xx unknown
- 1996-03-27 JP JP8072772A patent/JP3043610B2/ja not_active Expired - Lifetime
- 1996-03-27 AR ARP960101927A patent/AR001435A1/es unknown
- 1996-03-27 RU RU96105824/14A patent/RU2152785C1/ru active
- 1996-03-27 HU HU9600764A patent/HUP9600764A3/hu unknown
- 1996-03-27 CA CA002172778A patent/CA2172778C/fr not_active Expired - Lifetime
- 1996-03-28 US US08/620,805 patent/US5935586A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
MX9601151A (es)	1997-02-28
ATE201828T1 (de)	2001-06-15
EP0734728A1 (fr)	1996-10-02
FR2732220A1 (fr)	1996-10-04
JP3043610B2 (ja)	2000-05-22
EP0734728B1 (fr)	2001-06-06
HU9600764D0 (en)	1996-05-28
AR001435A1 (es)	1997-10-22
RU2152785C1 (ru)	2000-07-20
FR2732220B1 (fr)	1997-04-25
DE69613168T3 (de)	2009-03-05
JPH08268904A (ja)	1996-10-15
PL313511A1 (en)	1996-09-30
ES2159697T3 (es)	2001-10-16
DE69613168T2 (de)	2001-09-27
ES2159697T5 (es)	2008-07-01
CA2172778C (fr)	2008-02-12
US5935586A (en)	1999-08-10
DE69613168D1 (de)	2001-07-12
HUP9600764A2 (en)	1997-06-30
BR9601467A (pt)	1998-03-31
CA2172778A1 (fr)	1996-09-29
EP0734728B2 (fr)	2008-02-13

Similar Documents

Publication	Publication Date	Title
HUP9600765A2 (en)	1997-06-30	Use of a calcitonin gene related peptide antagonists for treating skin redness of neurogenic origin, and compositions containing this compound
HUP9600764A2 (en)	1997-06-30	Use of a cgrp calcitonin gene related peptide antagonists for treating lichens and pruritus, and compositions containing this compound
AU4348893A (en)	1994-01-24	Neuropeptide y antagonists
PL320010A1 (en)	1997-09-01	Indolyllic antagonists of neuropeptide y receptors
PL336797A1 (en)	2000-07-17	Therapeutic agent for treating cachexy
HUP9900964A3 (en)	2001-02-28	Protease inhibitors and pharmaceutical compositions containing these compounds
HUP0001293A3 (en)	2000-09-28	Heterocyclic compounds and their use for inhibiting betha-amyloid peptide
GR960300058T1 (en)	1996-11-30	Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
PL339617A1 (en)	2001-01-02	Novel antagonists of neuropeptide y
SI0741971T1 (en)	2001-04-30	Biocidal compositions comprising mixtures of halopropynyl compounds and sulphur containing triazines
PL338004A1 (en)	2000-09-25	Derivatives of azetidinylpropylpiperidine, intermediate compounds and application of such derivatives as antagonists of tachykinins
IL107323A (en)	2000-06-01	Pharmaceutical compositions containing 5-(N-heterosubstituted amino) quinolones and several such new compounds
AU2130795A (en)	1995-10-23	Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
HUP9600766A2 (en)	1997-06-30	Use of calcitonin gene related peptide antagonists for the treatment of pruritus and ocular or palpebral dysaesthesias and compositions containing this compound
IL117656A0 (en)	1996-07-23	Pharmaceutical compositions for the treatment of travellers diarrhea
IL132520A0 (en)	2001-03-19	A pharmaceutical composition for treating skin disorders containing a protein kinase c inhibitor
BG103632A (en)	2000-03-31	Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
EP0769530A3 (en)	1997-08-13	Monoazo metal compound, composition containing the same, charge control agents, toners and powdered lacquers
IL117655A0 (en)	1996-07-23	Pharmaceutical compositions for the treatment of travellers diarrhea
HUP9801879A3 (en)	1999-07-28	Pyridazinone-derivatives as endothelin-receptor antagonists, use thereof, pharmaceutical compositions containing these compounds and process for the preparation of the compounds and the compositions
FR2786097B1 (fr)	2003-08-15	Compositions amincissantes, a usage cosmetique ou dermopharmaceutique, contenant un extrait de dioscorea opposita
PL338083A1 (en)	2000-09-25	Compositions containing a metal salt and powdered metal obtained by calcination of such salt
AU7334794A (en)	1995-02-28	Efflorescence inhibiting cement composition
HUP9602253A3 (en)	1999-06-28	Endothelin-receptor antagonists, pharmaceutical compositions containing the same and process for their preparations
GB2266050B (en)	1995-08-16	Mixer valve for personal shower systems